Cargando…

A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B

BACKGROUND: Preventing liver fibrosis from progressing to cirrhosis and even liver cancer is a key step in the treatment of chronic hepatitis B (CHB). This study is aimed at constructing and validating a new nomogram for predicting significant liver fibrosis (S ≥ 2) in CHB patients. METHODS: The nom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yaqiong, Gong, Jiao, Zhou, Wenying, Jie, Yusheng, Li, Zhaoxia, Chong, Yutian, Hu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368191/ https://www.ncbi.nlm.nih.gov/pubmed/32695818 http://dx.doi.org/10.1155/2020/6839137

Ejemplares similares

Low Platelet to White Blood Cell Ratio Indicates Poor Prognosis for Acute-On-Chronic Liver Failure
por: Jie, Yusheng, et al.
Publicado: (2018)

Nomogram based on blood lipoprotein for estimation of mortality in patients with hepatitis B virus-related acute-on-chronic liver failure
por: Xiao, Cuicui, et al.
Publicado: (2020)

The Immune Landscape of Hepatitis B Virus-Related Acute Liver Failure by Integration Analysis
por: Gong, Jiao, et al.
Publicado: (2022)

Prognostic Value of Inflammatory Indicators in Chronic Hepatitis B Patients With Significant Liver Fibrosis: A Multicenter Study in China
por: Zhang, Xiujuan, et al.
Publicado: (2021)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Increased Expression of Fibulin-1 Is Associated With Hepatocellular Carcinoma Progression by Regulating the Notch Signaling Pathway
por: Gong, Jiao, et al.
Publicado: (2020)

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
por: Tsuji, Yuki, et al.
Publicado: (2020)

APRI Score as a Predictor of Significant Liver Fibrosis in Chronic Hepatitis B
por: Ayed, Houda Ben, et al.
Publicado: (2017)

Development and Validation of a Novel Risk Prediction Model Using Recursive Feature Elimination Algorithm for Acute-on-Chronic Liver Failure in Chronic Hepatitis B Patients With Severe Acute Exacerbation
por: Yu, Mingxue, et al.
Publicado: (2021)

Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA
por: Shi, Hong, et al.
Publicado: (2016)

TDF Monotherapy Is Effective Regardless of Prior Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patients in China
por: Huang, Mingxing, et al.
Publicado: (2017)

Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma
por: Yu, Mingxue, et al.
Publicado: (2021)

Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis
por: Qi, Xiaolong, et al.
Publicado: (2018)

Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer
por: Cao, Jing, et al.
Publicado: (2021)

Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B
por: Zeng, Xianghua, et al.
Publicado: (2015)

U-Shaped Relationship of Low-Density Lipoprotein Cholesterol With Risk of Severe COVID-19 From a Multicenter Pooled Analysis
por: Gong, Jiao, et al.
Publicado: (2021)

A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B
por: Chen, Yan, et al.
Publicado: (2019)

Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B
por: Liu, Jianxue, et al.
Publicado: (2016)

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis
por: Sonneveld, Milan J., et al.
Publicado: (2020)

Prevalence and Determinants of Significant Liver Fibrosis by Vibration-Controlled Transient Elastography in Thai Chronic Hepatitis B Patients
por: Sirinawasatien, Apichet, et al.
Publicado: (2018)

Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China
por: Ren, Tianyi, et al.
Publicado: (2017)

Performance of Non-invasive Blood Parameters for Ruling Out Significant Liver Fibrosis in Patients with Chronic Hepatitis B
por: Khare, Shivam, et al.
Publicado: (2020)

Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

Quantification of liver fibrosis in chronic hepatitis B virus infection
por: Jieanu, CF, et al.
Publicado: (2015)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study
por: Xu, Wei, et al.
Publicado: (2022)

A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection
por: Zeng, Da-Wu, et al.
Publicado: (2016)

A New Model Using Routinely Available Clinical Parameters to Predict Significant Liver Fibrosis in Chronic Hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2011)

Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis
por: Gui, Hong-Lian, et al.
Publicado: (2020)

An early novel prognostic model for predicting 80-day survival of patients with COVID-19
por: Chen, Yaqiong, et al.
Publicado: (2022)

Chronic hepatitis B virus and liver fibrosis: A mathematical model
por: Friedman, Avner, et al.
Publicado: (2018)

Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase
por: Zhan, Jie, et al.
Publicado: (2023)

Significant Fibrosis Is Not Rare in Chinese Chronic Hepatitis B Patients with Persistent Normal ALT
por: Liao, Baolin, et al.
Publicado: (2013)

Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B
por: Noguchi, Ryuichi, et al.
Publicado: (2017)

A simple noninvasive model to predict significant fibrosis in children with chronic hepatitis B
por: Zhang, Kang-Ling, et al.
Publicado: (2021)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis
por: Dai, Yun-kai, et al.
Publicado: (2022)

Prediction Model of HBsAg Seroclearance in Patients with Chronic HBV Infection
por: Cao, Jing, et al.
Publicado: (2020)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C
por: Wu, Ye-Jiao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jnl0un360sici71nnkqvbcfao9